Skip to main content
SpringerLink
Log in

Neuroanesthesia and Coexisting Renal Problems

  • Chapter
  • First Online:
Co-existing Diseases and Neuroanesthesia

  • 568 Accesses

Abstract

Both the brain and kidney share strong functional interdependence in health as well as in disease [1, 2]. Neurocritically ill patients are at a high risk of acute kidney injury (AKI) [3–7], while patients with acute renal insult, receiving renal replacement therapy (RRT), are susceptible to varied neurological complications requiring emergent neurosurgical interventions [8]. AKI is known to be an acute systemic disease with serious distant organ effects and progression to chronic kidney disease (CKD) with long-term morbidity and mortality [9–11]. Hence, successful management of AKI in patients with an injured brain requires an in-depth understanding of the fluid and electrolyte homeostasis, as well as appropriate modifications of RRT in the acute setting [12, 13].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Davenport A. The brain and the kidney-organ cross talk and interactions. Blood Purif. 2008;26:526–36.

    Article  PubMed  Google Scholar 

  2. Nongnuch A, Panorchan K, Davenport A. Brain–kidney crosstalk. Crit Care. 2014;18:225.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Moore EM, Bellomo R, Nichol A, Harley N, Macisaac C, Cooper DJ. The incidence of acute kidney injury in patients with traumatic brain injury. Ren Fail. 2010;32(9):1060–5.

    Article  PubMed  Google Scholar 

  4. Ahmed M, Sriganesh K, Vinay B, Umamaheswara Rao GS. Acute kidney injury in survivors of surgery for severe traumatic brain injury: incidence, risk factors, and outcome from a tertiary neuroscience center in India. Br J Neurosurg. 2015;29(4):544–8.

    Article  PubMed  Google Scholar 

  5. Büttner S, Stadler A, Mayer C, et al. Incidence, risk factors, and outcome of acute kidney injury in neurocritical care. J Intensive Care Med. 2018;1:885066617748596. [Epub ahead of print]

    Google Scholar 

  6. Tujjar O, Belloni I, Hougardy JM, et al. Acute kidney injury after subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2017;29(2):140–9.

    Article  PubMed  Google Scholar 

  7. Mostofsky E, Wellenius GA, Noheria A, et al. Renal function predicts survival in patients with acute ischemic stroke. Cerebrovasc Dis. 2009;28(1):88–94.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Karunaratne K, Taube D, Khalil N, Perry R, Malhotra PA. Neurological complications of renal dialysis and transplantation. Pract Neurol. 2018;18(2):115–25.

    Article  PubMed  Google Scholar 

  9. Yap SC, Lee HT. Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence. Anesthesiology. 2012;116:1139–48.

    Article  PubMed  Google Scholar 

  10. Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol. 2015;26:1765–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Pourafkari L, Arora P, Porhomayon J, Dosluoglu HH, Arora P. Nader ND Acute kidney injury after non-cardiovascular surgery: risk factors and impact on development of chronic kidney disease and long-term mortality. Curr Med Res Opin. 2018;3:1–22. Epub ahead of print

    Google Scholar 

  12. Davenport A. Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis. 2001;37(3):457–66.

    Article  CAS  PubMed  Google Scholar 

  13. Davenport A. Changing the hemodialysis prescription for hemodialysis patients with subdural and intracranial hemorrhage. Hemodial Int. 2013;17(Suppl 1):S22–7.

    Article  PubMed  Google Scholar 

  14. Arnold R, Issar T, Krishnan AV, Pussell BA. Neurological complications in chronic kidney disease. JRSM Cardiovasc Dis. 2016;5:2048004016677687.

    PubMed  PubMed Central  Google Scholar 

  15. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116:85–97.

    Article  PubMed  Google Scholar 

  16. Mathew A, Devereaux PJ, O’Hare A, et al. Chronic kidney disease and postoperative mortality: a systematic review and meta-analysis. Kidney Int. 2008;73(9):1069–81.

    Article  CAS  PubMed  Google Scholar 

  17. De la Garza Ramos R, Jain A, Nakhla J, et al. Postoperative morbidity and mortality after elective anterior cervical fusion in patients with chronic and end-stage renal disease. World Neurosurg. 2016;95:480–5.

    Article  PubMed  Google Scholar 

  18. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–12.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.

    Article  Google Scholar 

  21. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(Suppl 2):S1–S266.

    Google Scholar 

  22. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.

    Article  Google Scholar 

  23. Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–35.

    Article  PubMed  Google Scholar 

  24. Just A. Mechanisms of renal blood flow autoregulation: dynamics and contributions. Am J Physiol Regul Integr Comp Physiol. 2007;292:R1–17.

    Article  CAS  PubMed  Google Scholar 

  25. Kurella Tamura M, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Kidney Dis. 2008;52:227–34.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ono M, Arnaoutakis GJ, Fine DM, et al. Blood pressure excursions below the cerebral autoregulation threshold during cardiac surgery are associated with acute kidney injury. Crit Care Med. 2013;41:464–71.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Dias C, Gaio AR, Monteiro E, et al. Kidney–brain link in traumatic brain injury patients? A preliminary report. Neurocrit Care. 2015;22:192–20.

    Article  PubMed  Google Scholar 

  28. Fang L, You H, Chen B, et al. Mannitol is an independent risk factor of acute kidney injury after cerebral trauma: a case control study. Ren Fail. 2010;32:673–9.

    Article  PubMed  CAS  Google Scholar 

  29. Salem S, Jankowski V, Asare Y, et al. Identification of the “vasoconstriction inhibiting factor” (VIF), a potent endogenous cofactor of angiotensin II acting on the AT2 receptor. Circulation. 2015;131:1426–34.

    Article  CAS  PubMed  Google Scholar 

  30. Kim MY, Park JH, Kang NR, et al. Increased risk of acute kidney injury associated with higher infusion rate of mannitol in patients with intracranial hemorrhage. J Neurosurg. 2014;120(6):1340–8.

    Article  PubMed  Google Scholar 

  31. Nomani AZ, Nabi Z, Rashid H, et al. Osmotic nephrosis with mannitol: review article. Ren Fail. 2014;36(7):1169–76.

    Article  CAS  PubMed  Google Scholar 

  32. Lin SY, Tang SC, Tsai LK, et al. Incidence and risk factors for acute kidney injury following mannitol infusion in patients with acute stroke: a retrospective cohort study. Medicine (Baltimore). 2015;94(47):e2032.

    Article  CAS  Google Scholar 

  33. Zeng J, Tong W, Zheng P. Decreased risk of acute kidney injury with intracranial pressure monitoring in patients with moderate or severe brain injury. J Neurosurg. 2013;119(5):1228–32.

    Article  PubMed  Google Scholar 

  34. Rabetoy GM, Fredrieks MR, Hostettler CF. Where the kidney is concerned, how much mannitol is too much. Ann Pharmacother. 1993;27:25–8.

    Article  CAS  PubMed  Google Scholar 

  35. Sadan O, Singbartl K, Kandiah PA, Martin KS, Samuels OB. Hyperchloremia is associated with acute kidney injury in patients with subarachnoid hemorrhage. Crit Care Med. 2017;45(8):1382–8.

    Article  CAS  PubMed  Google Scholar 

  36. Kumar AB, Shi Y, Shotwell MS, Richards J, Ehrenfeld JM. Hypernatremia is a significant risk factor for acute kidney injury after subarachnoid hemorrhage: a retrospective analysis. Neurocrit Care. 2015;22(2):184–91.

    Article  PubMed  Google Scholar 

  37. Jiang S, Shen Y, Zhao X. Hyperchloremia is associated with acute kidney injury in patients with aneurysmal subarachnoid hemorrhage: not sure. Crit Care Med. 2017;45(10):e1099.

    Article  PubMed  Google Scholar 

  38. Kheterpal S, Tremper KK, Heung M, et al. Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology. 2009;110:505–15.

    Article  PubMed  Google Scholar 

  39. McKinlay J, Tyson E, Forni LG. Renal complications of anaesthesia. Anaesthesia. 2018;73(Suppl 1):85–94.

    Article  PubMed  Google Scholar 

  40. Abelha FJ, Botelho M, Fernandes V, Barros H. Determinants of postoperative acute kidney injury. Crit Care. 2009;13:R79.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Zhao XJ, Zhu FX, Li S, Zhang HB, An YZ. Acute kidney injury is an independent risk factor for myocardial injury after noncardiac surgery in critical patients. J Crit Care. 2017;39:225–31.

    Article  PubMed  Google Scholar 

  42. Quinn Timothy D, Brovman Ethan Y, Aglio Linda S, Urman Richard D. Factors associated with an increased risk of perioperative cardiac arrest in emergent and elective craniotomy and spine surgery. Clin Neurol Neurosurg. 2017;161:6–13.

    Article  CAS  PubMed  Google Scholar 

  43. Sun LY, Wijeysundera DN, Tait GA, Beattie WS. Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology. 2015;123:515–23.

    Article  PubMed  Google Scholar 

  44. Li N, Zhao WG, Xu FL, Zhang WF, Gu WT. Neutrophil gelatinase-associated lipocalin as an early marker of acute kidney injury in patients with traumatic brain injury. J Nephrol. 2013;26(6):1083–8.

    Article  PubMed  CAS  Google Scholar 

  45. Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17:R25.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Donnelly J, Budohoski KP, Smielewski P, Czosnyka M. Regulation of the cerebral circulation: bedside assessment and clinical implications. Crit Care. 2016;20(1):129.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Herrler T, Tischer A, Meyer A, et al. The intrinsic renal compartment syndrome: new perspectives in kidney transplantation. Transplantation. 2010;89(1):40–6.

    Article  PubMed  Google Scholar 

  49. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308:1566–72.

    Article  CAS  PubMed  Google Scholar 

  50. Roquilly A, Loutrel O, Cinotti R, et al. Balanced versus chloride-rich solutions for fluid resuscitation in brain-injured patients: a randomised double-blind pilot study. Crit Care. 2013;17(2):R77.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Young P, Bailey M, Beasley R, et al. SPLIT Investigators, ANZICS CTG. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA 2015;314(16):1701–10.

    Article  CAS  PubMed  Google Scholar 

  52. Hafizah M, Liu CY, Ooi JS. Normal saline versus balanced-salt solution as intravenous fluid therapy during neurosurgery: effects on acid-base balance and electrolytes. J Neurosurg Sci. 2017;61:263–70.

    PubMed  Google Scholar 

  53. Hassan MH, Hassan WMNW, Zaini RHM, Shukeri WFWM, Abidin HZ, Eu CS. Balanced fluid versus saline-based fluid in post-operative severe traumatic brain injury patients: acid-base and electrolytes assessment. Malays J Med Sci. 2017;24(5):83–93.

    PubMed  PubMed Central  Google Scholar 

  54. Wiedermann CJ, Dunzendorfer S, Gaioni LU, Zaraca F, Joannidis M. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care. 2010;14(5):R191.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367(20):1901–11.

    Article  CAS  PubMed  Google Scholar 

  56. Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309(7):678–88.

    Article  CAS  PubMed  Google Scholar 

  57. SAFE Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australian Red Cross Blood Service; George Institute for International Health, Myburgh J, Cooper DJ, Finfer S, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007;357(9):874–84.

    Article  Google Scholar 

  58. Teixeira C, Garzotto F, Piccinni P, et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care. 2013;17:R14.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Zhao Z, Wang D, Jia Y, et al. Analysis of the association of fluid balance and short-term outcome in traumatic brain injury. J Neurol Sci. 2016;364:12–8.

    Article  PubMed  Google Scholar 

  60. PRISM Investigators, Rowan KM, Angus DC, Bailey M, et al. Early, goal-directed therapy for septic shock — a patient-level meta-analysis. N Engl J Med. 2017;376:2223–34.

    Article  Google Scholar 

  61. Chou CY, Yeh HC, Chen W, et al. Norepinephrine and hospital mortality in critically ill patients undergoing continuous renal replacement therapy. Artif Organs. 2011;35:E11–7.

    PubMed  Google Scholar 

  62. Bellomo R, Wan L, May C. Vasoactive drugs and acute kidney injury. Crit Care Med. 2008;36:S179–86.

    Article  CAS  PubMed  Google Scholar 

  63. Uchino S, Doig GS, Bellomo R, et al., Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. Diuretics and mortality in acute renal failure. Crit Care Med 2004;32(8):1669–77

    Google Scholar 

  64. Ejaz AA, Mohandas R. Are diuretics harmful in the management of acute kidney injury? Curr Opin Nephrol Hypertens. 2014;23(2):155–60.

    Article  CAS  PubMed  Google Scholar 

  65. Mehta RL, Pascual MT, Soroko S, Chertow GM, PICARD Study Group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288(20):2547–53.

    Article  CAS  PubMed  Google Scholar 

  66. Yang B, Xu J, Xu F, et al. Intravascular administration of mannitol for acute kidney injury prevention: a systematic review and meta-analysis. PLoS One. 2014;9(1):e85029.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  67. Tamma PD, Turnbull AE, Harris AD, Milstone AM, Hsu AJ, Cosgrove SE. Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients. JAMA Pediatr. 2013;167:903–10.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with AKI: the ELAIN randomized clinical trial. JAMA. 2016;315:2190–9.

    Article  CAS  PubMed  Google Scholar 

  69. Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016;375:122–33.

    Article  PubMed  Google Scholar 

  70. Biondi-Zoccai G, Lotrionte M, Thomsen HS, et al. Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis. Int J Cardiol. 2014;172(2):375–80.

    Article  PubMed  Google Scholar 

  71. Han XF, Zhang XX, Liu KM, Tan H, Zhang Q. Contrast-induced nephropathy in patients with diabetes mellitus between iso- and low-osmolar contrast media: a meta-analysis of full-text prospective, randomized controlled trials. PLoS One. 2018;13(3):e0194330.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  72. John M. Eisenberg Center for Clinical Decisions and Communications Science. Contrast-Induced Nephropathy (CIN): Current State of the Evidence on Contrast Media and Prevention of CIN. Comparative effectiveness review summary guides for clinicians [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2007–2016 Aug 18.

    Google Scholar 

  73. Mamoulakis C, Tsarouhas K, Fragkiadoulaki I, et al. Contrast-induced nephropathy: basic concepts, pathophysiological implications and prevention strategies. Pharmacol Ther. 2017;180:99–112.

    Article  CAS  PubMed  Google Scholar 

  74. Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006;100:S11–5.

    Article  CAS  Google Scholar 

  75. Chavakula V, Gross BA, Frerichs KU, Du R. Contrast-induced nephropathy in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2013;19(2):157–60.

    Article  CAS  PubMed  Google Scholar 

  76. Brinjikji W, Demchuk AM, Murad MH, et al. Neurons over nephrons: systematic review and meta-analysis of contrast-induced nephropathy in patients with acute stroke. Stroke. 2017;48(7):1862–8.

    Article  PubMed  Google Scholar 

  77. Kim J, Male S, Jagadeesan BD, Streib C, Tummala RP. Safety of cerebral angiography and neuroendovascular therapy in patients with chronic kidney disease. Neuroradiology. 2018;60(5):529–33.

    Article  PubMed  Google Scholar 

  78. McDonald RJ, McDonald JS, Bida JP, et al. Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology. 2013;267(1):106–18.

    Article  PubMed  Google Scholar 

  79. Azzalini L, Candilio L, McCullough PA, Colombo A. Current risk of contrast-induced acute kidney injury after coronary angiography and intervention: a reappraisal of the literature. Can J Cardiol. 2017;33(10):1225–8.

    Article  PubMed  Google Scholar 

  80. Su X, Xie X, Liu L, et al. Comparative effectiveness of 12 treatment strategies for preventing contrast-induced acute kidney injury: a systematic review and Bayesian network meta-analysis. Am J Kidney Dis. 2017;69(1):69–77.

    Article  CAS  PubMed  Google Scholar 

  81. Ma WQ, Zhao Y, Wang Y, Han XQ, Zhu Y, Liu NF. Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials. Int Urol Nephrol. 2018;50(6):1085–95.

    Article  CAS  PubMed  Google Scholar 

  82. Mattathil S, Ghumman S, Weinerman J, Prasad A. Use of the RenalGuard system to prevent contrast-induced AKI: a meta-analysis. J Interv Cardiol. 2017;30(5):480–7.

    Article  PubMed  Google Scholar 

  83. Kassis HM, Minsinger KD, McCullough PA, Block CA, Sidhu MS, Brown JR. A review of the use of Iloprost, a synthetic prostacyclin, in the prevention of radiocontrast nephropathy in patients undergoing coronary angiography and intervention. Clin Cardiol. 2015;38(8):492–8.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Dai B, Liu Y, Fu L, Li Y, Zhang J, Mei C. Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2012;60(3):360–70.

    Article  CAS  PubMed  Google Scholar 

  85. Albabtain MA, Almasood A, Alshurafah H, Alamri H, Tamim H. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast induced nephropathy: a prospective randomized study. J Interv Cardiol. 2013;26(1):90–6.

    Article  PubMed  Google Scholar 

  86. Ibrahim TA, El-Mawardy RH, El-Serafy AS, El-Fekky EM. Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease. Cardiovasc Revasc Med. 2017;18(5):315–9.

    Article  PubMed  Google Scholar 

  87. Long B, Koyfman A, Lee CM. Emergency medicine evaluation and management of the end stage renal disease patient. Am J Emerg Med. 2017;35(12):1946–55.

    Article  PubMed  Google Scholar 

  88. Babb AL, Ahmad S, Bergström J, et al. The middle molecule hypothesis in perspective. Am J Kidney Dis. 1981;1:46–50.

    Article  CAS  PubMed  Google Scholar 

  89. Sood P, Sinson GP, Cohen EP. Subdural hematomas in chronic dialysis patients: significant and increasing. Clin J Am Soc Nephrol. 2007;2:956–9.

    Article  PubMed  Google Scholar 

  90. Neumann HP, Malinoc A, Bacher J, et al. Characteristics of intracranial aneurysms in the else kröner-fresenius registry of autosomal dominant polycystic kidney disease. Cerebrovasc Dis Extra. 2012;2:71–9.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Kawamura M, Fijimoto S, Hisanaga S, Yamamoto Y, Eto T. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am J Kidney Dis. 1998;31:991–6.

    Article  CAS  PubMed  Google Scholar 

  92. Iseki K, Fukiyama K. Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis Study (OKIDS) Group. Nephrol Dial Transplant. 2000;15:2008–13.

    Article  Google Scholar 

  93. Sozio SM, Armstrong PA, Coresh J, et al. Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Am J Kidney Dis. 2009;54:468–77.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Winkelmayer WC, Liu J, Setoguchi S, Choudhry NK. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol. 2011;6:2662–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Kumar A, Cage A, Dhar R. Dialysis-induced worsening of cerebral edema in intracranial hemorrhage: a case series and clinical perspective. Neurocrit Care. 2015;22(2):283–7.

    Article  PubMed  Google Scholar 

  96. Lopez-Almaraz E, Correa-Rotter R. Dialysis disequilibrium syndrome and other treatment complications of extreme uremia: a rare occurrence yet not vanished. Hemodial Int. 2008;12:301–6.

    Article  PubMed  Google Scholar 

  97. Rabindranath K, Adams J, Macleod AM, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007(3):CD003773.

  98. Osgood M, Muehlschlegel S. Should continuous venovenous hemofiltration always be the preferred mode of renal replacement therapy for the patient with acute brain injury? Yes. Chest. 2017;152(6):1109–11.

    Article  PubMed  Google Scholar 

  99. Osgood M, Compton R, Carandang R, Hall W, Kershaw G, Muehlschlegel S. Rapid unexpected brain herniation in association with renal replacement therapy in acute brain injury: caution in the neurocritical care unit. Neurocrit Care. 2015;22(2):176–83.

    Article  PubMed  Google Scholar 

  100. Davenport A. Intradialytic complications during hemodialysis. Hemodial Int. 2006;10:162–7.

    Article  PubMed  Google Scholar 

  101. Davenport A. Continuous vs intermittent forms of haemofiltration and/or dialysis in management of acute renal failure with defective cerebral autoregulation at risk of cerebral oedema. Contrib Nephrol. 1991;93:225–33.

    Article  CAS  PubMed  Google Scholar 

  102. Davenport A. Practical guidance for dialyzing a hemodialysis patient following acute brain injury. Hemodial Int. 2008;12(3):307–12.

    Article  PubMed  Google Scholar 

  103. Zhang L, Yang J, Eastwood GM, Zhu G, Tanaka A, Bellomo R. Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury: a metaanalysis. Am J Kidney Dis. 2015;66(2):322–30.

    Article  PubMed  Google Scholar 

  104. Jörres A, John S, Lewington A, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: Part 2: Renal replacement therapy. Nephrol Dial Transplant. 2013;28(12):2940–5.

    Article  PubMed  Google Scholar 

  105. Shoji T, Tsubakihara Y, Fujii M, et al. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int. 2004;66(3):1212–20.

    Article  PubMed  Google Scholar 

  106. Masson P, Webster AC, Hong M, Turner R, Lindley RI, Craig JC. Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis. Nephrol Dial Transplant. 2015;30(7):1162–9.

    Article  CAS  PubMed  Google Scholar 

  107. Roth C, Ferbert A. The posterior reversible encephalopathy syndrome: what’s certain, what’s new? Pract Neurol. 2011;11:136–44.

    Article  CAS  PubMed  Google Scholar 

  108. Jung JM, Kim HJ, Ahn H, et al. Chronic kidney disease and intravenous thrombolysis in acute stroke: a systematic review and metaanalysis. J Neurol Sci. 2015;358(1–2):345–50.

    Article  PubMed  Google Scholar 

  109. Thermann F, Kornhuber M. Ischemic monomelic neuropathy: a rare but important complication after hemodialysis access placement--a review. J Vasc Access. 2011;12(2):113–9.

    Article  PubMed  Google Scholar 

  110. Arnold R, Pussell BA, Howells J, et al. Evidence for a causal relationship between hyperkalaemia and axonal dysfunction in end-stage kidney disease. Clin Neurophysiol. 2014;125:179–85.

    Article  PubMed  Google Scholar 

  111. Chan KE, Ikizler TA, Gamboa JL, et al. Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients. Kidney Int. 2011;80:978–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Matsue Y, Suzuki M, Nagahori W, et al. Beta-blocker prevents sudden cardiac death in patients with hemodialysis. Int J Cardiol. 2013;165:519–22.

    Article  PubMed  Google Scholar 

  113. Curtis BM, Parfrey PS. Congestive heart failure in chronic kidney disease: disease-specific mechanisms of systolic and diastolic heart failure and management. Cardiol Clin. 2005;23(3):275–84.

    Article  PubMed  Google Scholar 

  114. Wang AY, Lam CW, Chan IH, et al. Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis. Hypertension. 2010;56(2):210–6.

    Article  CAS  PubMed  Google Scholar 

  115. Yigla M, Fruchter O, Aharonson D, et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int. 2009;75:969–75.

    Article  PubMed  Google Scholar 

  116. McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004;20:1501–10.

    Article  PubMed  Google Scholar 

  117. Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin Dial. 2006;19(4):317–22.

    Article  PubMed  Google Scholar 

  118. Mercier E, Branger B, Vecina F, et al. Tissue factor coagulation pathway and blood cells activation state in renal insufficiency. Hematol J. 2001;2(1):18–25.

    Article  CAS  PubMed  Google Scholar 

  119. Dagher GA, Harmouche E, Jabbour E, et al. Sepsis in hemodialysis patients. BMC Emerg Med. 2015;15:30.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  120. Davison SN. Pain in hemoalysis patients: prevalence, cause, severity, and management. Am J Kidney Dis. 2003;42(6):1239–47.

    Article  PubMed  Google Scholar 

  121. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–9.

    Article  CAS  PubMed  Google Scholar 

  122. Ferguson TW, Komenda P, Tangri N. Cystatin C as a biomarker for estimating glomerular filtration rate. Curr Opin Nephrol Hypertens. 2015;24(3):295–300.

    Article  CAS  PubMed  Google Scholar 

  123. De Vriese AS, Vandecasteele SJ, Van den Bergh B, et al. Should we screen for coronary artery disease in asymptomatic chronic dialysis patients? Kidney Int. 2012;81(2):143–51.

    Article  PubMed  Google Scholar 

  124. Stacy SR, Suarez-Cuervo C, Berger Z, et al. Role of troponin in patients with chronic kidney disease and suspected acute coronary syndrome: a systematic review. Ann Intern Med. 2014;161:502.

    Article  PubMed  Google Scholar 

  125. Breidthardt T, Kalbermatter S, Socrates T, et al. Increasing B-type natriuretic peptide levels predict mortality in unselected haemodialysis patients. Eur J Heart Fail. 2011;13(8):860–7.

    Article  CAS  PubMed  Google Scholar 

  126. Renew JR, Pai SL. A simple protocol to improve safety and reduce cost in hemodialysis patients undergoing elective surgery. Middle East J Anaesthesiol. 2014;22(5):487–92.

    PubMed  Google Scholar 

  127. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2:279–335.

    Article  Google Scholar 

  128. Casserly LF, Dember LM. Thrombosis in end-stage renal disease. Semin Dial. 2003;16(3):245–56.

    Article  PubMed  Google Scholar 

  129. Zhu X, Perazella MA. Nonhematologic complications of erythropoietin therapy. Semin Dial. 2006;19(4):279–84.

    Article  PubMed  Google Scholar 

  130. Rahbar M, Chitsazian Z, Abdoli F, Moeini Taba SM, Akbari H. Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients. J Nephropathol. 2017;6(1):25–9.

    Article  PubMed  Google Scholar 

  131. Badenes R, Oddo M, Suarez JI, et al. Hemoglobin concentrations and RBC transfusion thresholds in patients with acute brain injury: an international survey. Crit Care. 2017;21(1):159.

    Article  PubMed  PubMed Central  Google Scholar 

  132. Christensen JH, Andreasen F, Jansen J. Pharmacokinetics and pharmacodynamics of thiopental in patients undergoing renal transplantation. Acta Anaesthesiol Scand. 1983;27(6):513–8.

    Article  CAS  PubMed  Google Scholar 

  133. Takizawa D, Hiraoka H, Goto F, et al. Human kidneys play an important role in the elimination of propofol. Anesthesiology. 2005;102(2):327–30.

    Article  CAS  PubMed  Google Scholar 

  134. De Wolf AM, Fragen RJ, Avram MJ, et al. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg. 2001;93(5):1205–9.

    Article  PubMed  Google Scholar 

  135. Swart EL, Zuideveld KP, de Jongh J, Danhof M, Thijs LG, Strack van Schijndel RM. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. Br J Clin Pharmacol. 2004;57(2):135–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  136. Litz RJ, Hubler M, Lorenz W, et al. Renal responses to desflurane and isoflurane in patients with renal insufficiency. Anesthesiology. 2002;97:1133–6.

    Article  CAS  PubMed  Google Scholar 

  137. Mazze RI, Callan CM, Galvez ST, et al. The effects of sevoflurane on serum creatinine and blood urea nitrogen concentrations: a retrospective, twenty-two-center, comparative evaluation of renal function in adult surgical patients. Anesth Analg. 2000;90:683–8.

    Article  CAS  PubMed  Google Scholar 

  138. Thapa S, Brull SJ. Succinylcholine-induced hyperkalemia in patients with renal failure: an old question revisited. Anesth Analg. 2000;91:237–41.

    CAS  PubMed  Google Scholar 

  139. Webb MD. Type I second-degree AV block after neostigmine administration in a child with renal failure. Anesth Prog. 1995;42(1):21–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  140. Panhuizen IF, Gold SJ, Buerkle C, et al. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment. Br J Anaesth. 2015;114(5):777–84.

    Article  CAS  PubMed  Google Scholar 

  141. Mallappallil M, Sabu J, Friedman EA, Salifu M. What do we know about opioids and the kidney? Int J Mol Sci 2017;18(1). pii: E223.

    Google Scholar 

  142. Kurella M, Bennett WM, Chertow GM. Analgesia in patients with ESRD: a review of available evidence. Am J Kidney Dis. 2003;42(2):217–28.

    Article  CAS  PubMed  Google Scholar 

  143. Breen D, Wilmer A, Bodenham A, et al. Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment. Crit Care. 2004;8(1):R21–30.

    Article  PubMed  Google Scholar 

  144. Dahaba AA, Oettl K, Von Klobucar F, et al. End-stage renal failure reduces central clearance and prolongs the elimination half life of remifentanil. Can J Anaesth. 2002;49:369–74.

    Article  PubMed  Google Scholar 

  145. Brune K, Renner B, Tiegs G. Acetaminophen/paracetamol: a history of errors, failures and false decisions. Eur J Pain. 2015;19(7):953–65.

    Article  CAS  PubMed  Google Scholar 

  146. Roberts E, Delgado Nunes V, Buckner S, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75(3):552–9.

    Article  CAS  PubMed  Google Scholar 

  147. Schneider V, Levesque LE, Zhang B, et al. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based, nested case-control analysis. Am J Epidemiol. 2006;164:881–9.

    Article  PubMed  Google Scholar 

  148. Chang YK, Liu JS, Hsu YH, et al. Increased risk of end-stage renal disease (ESRD) requiring chronic dialysis is associated with use of nonsteroidal anti-inflammatory drugs (NSAIDs). Medicine (Baltimore). 2015;94(38):e1362.

    Article  CAS  Google Scholar 

  149. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2:337–414.

    Article  Google Scholar 

  150. Wilcox CS. New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol. 2002;13(3):798–805.

    PubMed  Google Scholar 

  151. Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH. Chronic kidney disease, fluid overload and diuretics: a complicated triangle. PLoS One. 2016;11(7):e0159335.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  152. Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine (Baltimore). 1990;69(3):153–9.

    Article  CAS  Google Scholar 

  153. Hirsch KG, Spock T, Koenig MA, Geocadin RG. Treatment of elevated intracranial pressure with hyperosmolar therapy in patients with renal failure. Neurocrit Care. 2012;17(3):388–94.

    Article  PubMed  Google Scholar 

  154. Wilbur J, Shian B. Deep venous thrombosis and pulmonary embolism: current therapy. Am Fam Physician. 2017;95(5):295–302.

    PubMed  Google Scholar 

  155. Frydman A. Low-molecular-weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humans. Haemostasis. 1996;26(Suppl 2):24–38.

    CAS  PubMed  Google Scholar 

  156. Lim W, Dentali F, Eikelboom JW, Crowther MA. Meta-analysis: low molecular- weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med. 2006;144:673–84.

    Article  CAS  PubMed  Google Scholar 

  157. Park D, Southern W, Calvo M, et al. Treatment with dalteparin is associated with a lower risk of bleeding compared to treatment with unfractionated heparin in patients with renal insufficiency. J Gen Intern Med. 2016;31(2):182–7.

    Article  PubMed  Google Scholar 

  158. Lazrak HH, René É, Elftouh N, Leblanc M, Lafrance JP. Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis. BMC Nephrol. 2017;18(1):187.

    Article  PubMed  PubMed Central  Google Scholar 

  159. Kessler M, Moureau F, Nguyen P. Anticoagulation in chronic hemodialysis: progress toward an optimal approach. Semin Dial. 2015;28(5):474–89.

    Article  PubMed  Google Scholar 

  160. Duranteau J, Taccone FS, Verhamme P, Ageno W, ESA VTE Guidelines Task Force. European guidelines on perioperative venous thromboembolism prophylaxis: intensive care. Eur J Anaesthesiol. 2018;35(2):142–6.

    PubMed  Google Scholar 

  161. Szummer K, Gasparini A, Eliasson S, et al. Time in therapeutic range and outcomes after warfarin initiation in newly diagnosed atrial fibrillation patients with renal dysfunction. J Am Heart Assoc. 2017;6(3):e004925.

    Article  PubMed  PubMed Central  Google Scholar 

  162. Dahal K, Kunwar S, Rijal J, Schulman P, Lee J. Stroke, major bleeding, and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease: a meta-analysis of observational studies. Chest. 2016;149(4):951–9.

    Article  PubMed  Google Scholar 

  163. Harel Z, Chertow GM, Shah PS, et al. Warfarin and the risk of stroke and bleeding in patients with atrial fibrillation receiving dialysis: a systematic review and meta-analysis. Can J Cardiol. 2017;33(6):737–46.

    Article  PubMed  Google Scholar 

  164. Nielsen PB, Lane DA, Rasmussen LH, Lip GY, Larsen TB. Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysis. Clin Res Cardiol. 2015;104(5):418–29.

    Article  CAS  PubMed  Google Scholar 

  165. Heidbuchel H, Verhamme P, Alings M, et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2015;17(10):1467–507.

    Article  PubMed  Google Scholar 

  166. Kimachi M, Furukawa TA, Kimachi K, Goto Y, Fukuma S, Fukuhara S. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. Cochrane Database Syst Rev 2017;(11):CD011373.

    Google Scholar 

  167. Bansal AD, Hill CE, Berns JS. Use of antiepileptic drugs in patients with chronic kidney disease and end stage renal disease. Semin Dial. 2015;28(4):404–12.

    Article  PubMed  Google Scholar 

  168. Al-mustafa MM, Massad I, Alsmady M, et al. The effect of low serum bicarbonate values on the onset of action of local anesthesia with vertical infraclavicular brachial plexus block in patients with end-stage renal failure. Saudi J Kidney Dis Transpl. 2010;21(3):494–500.

    PubMed  Google Scholar 

  169. Ickx B, Cockshott ID, Barvais L, et al. Propofol infusion for induction and maintenance of anaesthesia in patients with end-stage renal disease. Br J Anaesth. 1998;81(6):854–60.

    Article  CAS  PubMed  Google Scholar 

  170. Wu X, Zhang W, Ren H, et al. Diuretics associated acute kidney injury: clinical and pathological analysis. Ren Fail. 2014;36:1051–5.

    Article  CAS  PubMed  Google Scholar 

  171. Luo J, Xue J, Liu J, Liu B, Liu L, Chen G. Goal-directed fluid restriction during brain surgery: a prospective randomized controlled trial. Ann Intensive Care. 2017;7(1):16.

    Article  PubMed  PubMed Central  Google Scholar 

  172. Kanda H, Hirasaki Y, Iida T, et al. Perioperative management of patients with end-stage renal disease. J Cardiothorac Vasc Anesth. 2017;31(6):2251–67.

    Article  PubMed  Google Scholar 

  173. Lan H, Zhou X, Xue J, Liu B, Chen G. The ability of left ventricular end-diastolic volume variations measured by TEE to monitor fluid responsiveness in high-risk surgical patients during craniotomy: a prospective cohort study. BMC Anesthesiol. 2017;17(1):165.

    Article  PubMed  PubMed Central  Google Scholar 

  174. Chemtob RA, Eskesen TG, Moeller-Soerensen H, et al. Systematic review of the association of venous oxygenation and outcome in adult hospitalized patients. Acta Anaesthesiol Scand. 2016;60(10):1367–78.

    Article  CAS  PubMed  Google Scholar 

  175. Taler SJ, Agarwal R, Bakris GL, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis. 2013;62(2):201–13.

    Article  PubMed  PubMed Central  Google Scholar 

  176. McMurray JJ, Adamopoulos S, Anker SD, et al., ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14(8):803–69.

    Google Scholar 

  177. Galbusera M, Remuzzi G, Boccardo P. Treatment of bleeding in dialysis patients. Semin Dial. 2009;22(3):279–86.

    Article  PubMed  Google Scholar 

  178. Naidech AM, Maas MB, Levasseur-Franklin KE, et al. Desmopressin improves platelet activity in acute intracerebral hemorrhage. Stroke. 2014;45(8):2451–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  179. Vujkovac B, Sabovic M. Treatment of subdural and intracerebral haematomas in a haemodialysis patient with tranexamic acid. Nephrol Dial Transplant. 2000;15:107–9.

    Article  CAS  PubMed  Google Scholar 

  180. Kalantar-Zadeh K, Derose SF, Nicholas S, et al. Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus. J Ren Nutr. 2009;19(1):33–7.

    Article  PubMed  PubMed Central  Google Scholar 

  181. Betônico CC, Titan SM, Correa-Giannella ML, Nery M, Queiroz MS. Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control. Clinics. 2016;71(1):47–53.

    Article  PubMed  PubMed Central  Google Scholar 

  182. Carman TL, Kanner AA, Barnett GH, et al. Prevention of thromboembolism after neurosurgery for brain and spinal tumors. South Med J. 2003;96:17–22.

    Article  PubMed  Google Scholar 

  183. Smith TR, Nanney AD III, Lall RR, et al. Development of venous thromboembolism (VTE) in patients undergoing surgery for brain tumors: results from a single center over a 10 year period. J Clin Neurosci. 2015;22(3):519–25.

    Article  PubMed  Google Scholar 

  184. Denson K, Morgan D, Cunningham R, et al. Incidence of venous thromboembolism in patients with traumatic brain injury. Am J Surg. 2007;193:380–3.

    Article  PubMed  Google Scholar 

  185. Skaf E, Stein PD, Beemath A, Sanchez J, Bustamante MA, Olson RE. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol. 2005;96(12):1731–3.

    Article  PubMed  Google Scholar 

  186. Kshettry VR, Rosenbaum BP, Seicean A, Kelly ML, Schiltz NK, Weil RJ. Incidence and risk factors associated with in hospital venous thromboembolism after aneurysmal subarachnoid hemorrhage. J Clin Neurosci. 2014;21(2):282–6.

    Article  PubMed  Google Scholar 

  187. Faraoni D, Comes RF, Geerts W, Wiles MD, ESA VTE Guidelines Task Force. European guidelines on perioperative venous thromboembolism prophylaxis: neurosurgery. Eur J Anaesthesiol. 2018;35(2):90–5.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuroanaesthesia, Indraprastha Apollo Hospital, New Delhi, India

    Nidhi Gupta

  2. Max Superspeciality Hospital, Ghaziabad, Uttar Pradesh, India

    Shiwani Aggarwal

  3. Department of Neuroanesthesiology and Neurocritical Care, Medanta, The Medicity, Gurugram, India

    Vasudha Singhal

Authors
  1. Nidhi Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shiwani Aggarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vasudha Singhal
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences, New Delhi, India

    Hemanshu Prabhakar

  2. Department of Neuroanesthesiology and Neurocritical Care, Medanta, The Medicity, Gurugram, India

    Vasudha Singhal

  3. Department of Neuroanaesthesia, Indraprastha Apollo Hospital, New Delhi, India

    Nidhi Gupta

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gupta, N., Aggarwal, S., Singhal, V. (2019). Neuroanesthesia and Coexisting Renal Problems. In: Prabhakar, H., Singhal, V., Gupta, N. (eds) Co-existing Diseases and Neuroanesthesia. Springer, Singapore. https://doi.org/10.1007/978-981-13-2086-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-2086-6_7

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-2085-9

  • Online ISBN: 978-981-13-2086-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation